Laborate Pharmaceutical’s Aqualab achieves ₹100 crore revenue, eyes ₹250 crore with retail-first model

Aqualab, retail arm of Laborate Pharmaceuticals India, crossed ₹100 crore revenue in three years and targets ₹250 crore by FY25–26. Its 800+ SKUs and 500+ stockists drive Tier-II/III expansion. MD Arpit Bhatia cites scaling Direct-to-Retail and last-mile delivery. Leveraging Laborate’s GMP-certified facilities, Aqualab eyes exports, digital channels, and new categories in India’s ₹18,700 crore retail pharmacy market, projected at ₹31,200 crore by FY32. Founded 1985, Laborate operates in 55 countries.